Showing results (1661-1670 of 1,805) with videos related to
Sort By:
Pageof 181
Journal of Gastrointestinal Cancer|February 1, 2023
Effect of Time to Minimally Invasive Esophagectomy After Neoadjuvant Chemotherapy for Esophageal Squamous Cell CarcinomaNguyen Vo Vinh Loc, Nguyen Lam Vuong, Lam Viet Trung, et al.Journal of Gastrointestinal Cancer|March 14, 2023
Attitudes of Gastroenterologists Regarding Delivery of Cancer Diagnoses: a Cross-Sectional StudyAbdelwahab Ahmed, Arif Musa, Shannon Lohman, et al.Journal of Gastrointestinal Cancer|November 18, 2022
Enhancing the Anti-angiogenic Effect of Bevacizumab with ACE Inhibition on mCRCEfe Cem Erdat, Elif Berna Koksoy, Gungor UtkanJournal of Gastrointestinal Cancer|November 27, 2025
Radioembolization in Hepatocellular Carcinoma: Indications and OutcomesBahareh Gholami, Ali Afrasiabi, Paolo Varela, et al.Journal of Gastrointestinal Cancer|November 21, 2025
Association of Spirometric Lung Age with Survival Outcomes in Elderly Patients Undergoing Radical Surgery for Gastric CancerMasayuki Urabe, Mami Suzuki, Takahiro Fukai, et al.Journal of Gastrointestinal Cancer|November 16, 2025
Clinicopathological Factors and Nomogram Construction for Lymph Node Metastasis in Early-Onset Colorectal CancerXu Sun, Rui Li, Wen Zhao, et al.Journal of Gastrointestinal Cancer|November 14, 2025
Misdiagnosis of Suspected Cancer in Pancreatoduodenectomy: A Systematic Review and Prevalence Mata-AnalysisLuis F Leite da Siva, Luiz F Costa de Almeida, Marcos Belotto, et al.Journal of Gastrointestinal Cancer|January 14, 2026
Prognostic Value of albumin-bilirubin (ALBI) Grade in Patients with Gastric Cancer: A Systematic Review and meta-analysisMahyaar Omouri-Kharashtomi, Hamed Ghoshouni, Ariyan Ayati Firoozabadi, et al.Journal of Gastrointestinal Cancer|January 13, 2026
Outcomes of Ramucirumab Monotherapy for Advanced Gastric Cancer in a Multi-institutional Cohort Study in JapanYoshinori Kikuchi, Sakae Nagaoka, Nobue Futawatari, et al.Journal of Gastrointestinal Cancer|January 7, 2026
The Vascular Density/Angiogenesis Marker CD31/PECAM1 does not Correlate with Overall Survival in Neuroendocrine TumorsNicholas J Skill, Kenneth Avanzino, Yvette Bren-Mattison, et al.Pageof 181